BioCentury
ARTICLE | Company News

Bioheart, Invitrx deal

September 30, 2013 7:00 AM UTC

Invitrx granted Bioheart rights to Invitrx's adipose derived stem cell products for use in all indications in humans and animals. Bioheart intends to use these techniques to advance the development an...